[1]
|
Robert Koch Institut, “Krebs in Deutschland 2007/2008. H?ufigkeit und Trends,” 8th Revised Edition, RobertKoch-Institut und Gesellschaft für Epidemiologische Krebsregister in Deutschland e.V., Robert Koch Institut, Berlin, 2012. www.rki.de/krebs
|
[2]
|
Robert Koch Institute and Association of PopulationBased Cancer Registries in Germany, “Cancer in Germany 2005/2006. Incidence and Trends,” 17th Edition, Robert Koch Institute and Association of PopulationBased Cancer Registries in Germany, Berlin, 2010.
|
[3]
|
C. Smigal, A. Jemal, E. Ward, et al., “Trends in Breast Cancer by Race and Ethnicity: Update 2006,” CA: A Cancer Journal for Clinicians, Vol. 56, No. 3, 2006, pp. 168-183. http://dx.doi.org/10.3322/ canjclin.56.3.168
|
[4]
|
A. M. Brewster, G. N. Hortobagi, K. R. Brogilo, et al., “Residual Risk of Breast Cancer Recurrence 5 Years after Adjuvant Therapy,” Journal of the National Cancer Institute, Vol. 100, No. 16, 2008, pp. 1179-1183.
http://dx.doi.org/10.1093/jnci/djn233
|
[5]
|
D. Schon, J. Bertz, B. Gorsch, et al., “Die Dachdokumentation Krebs,” Gesundheitsbl-Gesundheitsforsch-Gesundheitsschutz, Vol. 47, No. 5, 2004, pp. 429-436.
http://dx.doi.org/10.1007/ s00103-004-0830-7
|
[6]
|
L. A. G. Ries and M. P. Eisner, “Cancer of the Female Breast,” In: L. A. G. Ries, G. E. Keel, M. P. Eisner, et al., Eds., SEER Survival Monograph: Cancer Survival among Adults, US SEER Program, 1988-2001, Patient and Tumor Characteristics, National Cancer Institute, NIH Publication, Bethesda, 2007, pp. 101-110.
|
[7]
|
G. M. Clark, G. W. Sledge Jr., C. K. Obsorneand W. L. McGuire, “Survival from First Recurrence: Relative Importance of Prognostic Factors in 1015 Breast Cancer Patient,” Journal of Clinical Oncology, Vol. 5, No. 1, 1987, pp. 55-61.
|
[8]
|
D. Schon, J. Bertz, B. Gorsch, et al., “Entwicklung der überlebensraten von Krebspatienten in Deutschland. Gesundheitsberichterstattung für Deutschland,” Robert Koch-Institut, Berlin, 1999.
|
[9]
|
J. W. Hrsg, “Manual Mammakarzinome: Empfehlung zur Diagnostik, Therapie und Nachsorge,” W. Zuckschwerdt Verlag, München, 2007.
|
[10]
|
J. R. Harris, M. Morrow and G. Bonnadona, “Cancer of the Breast,” In: V. T. De Vita Jr., S. Hellman, S. A. Rosenberg, et al., Eds., Cancer: Principles and Practice in Oncology, 4th Edition, JB Lippincott, Philadelphia, 1993, pp. 1264-1332.
|
[11]
|
F. Andre, K. Slimane, et al., “Breast Cancer with Synchronous Metastases: Trends in Survival during a 14-Year Period,” Journal of Clinical Oncology, Vol. 22, No. 16, 2004, pp. 3302-3308.
http://dx.doi.org/10.1200/JCO.2004.08.095
|
[12]
|
U. Dafni, I. Grimani, A. Xyrafas, A. G. Eleftheraki and G. Fountzilas, “Fifteen-Year Trends in Metastatic Breast Cancer Survival in Greece,” Breast Cancer Research and Treatment, Vol. 119, No. 3, 2010, pp. 621-631.
http://dx.doi.org/10.1007/s10549-009-0630-8
|
[13]
|
J. Gnerlich, D. B. Jeffe, A. D. Deshpande, J. C. Beers, C. Zander and J. A. Margenthaler, “Surgical Removal of the Primary Tumor Increases Overal Survival in üatients with Metastatic Breast Cacner: Analysis of the 1998-2003 SEER Data,” Annals of Surgical Oncology, Vol. 14, No. 8, 2007, pp. 2187-2194.
http://dx.doi.org/10.1245/s10434-007-9438-0
|
[14]
|
R. E. Mansel, O. Fodstad and W. E. Jiang, “Metastasis of Breast Cancer,” Cancer Metastasis—Biology and Treatment, Vol. 11, Springer, 2007, 435 p.
http://dx.doi.org/10.1007/978-1-4020-5867-7
|
[15]
|
A. Gennari, C. Pier-Franco, R. Rosso, C. Orlandini and P. Bruzzi, “Survival of Metastatic Breast Carcinoma Patients over a 20-Year Period. A Retrospective Analysis Based on Individual Patient Date from Six Consecutive Studies,” Cancer, Vol. 104, No. 8, 2005, pp. 1742-1750.
http://dx.doi.org/ 10.1002/cncr.21359
|
[16]
|
S. K. Chia, C. H. Speers, Y. Dyachkova, A. Kang, S. Malfair-Taylor, J. Barnett, I. A. Coldman, et al., “The Impact of New Chemotherapeutic and Hormone Agents on Survival in Population-Based Cohort of Women with Metastatic Breast Cancer,” Cancer, Vol. 110, No. 5, 2007, pp. 973-979. http://dx.doi.org/10.1002/cncr.22867
|
[17]
|
J. Barinoff, F. Heitz, P. Harter, F. Lorens-Salehi, A. Traut, A. du Bois, “Primar Metastasierendes Mammakarzinom: Gesamtüberleben im Zeitlichen Verlauf,” Senologie, Vol. 6, 2009, pp. 177-194.
|
[18]
|
R. C. Fields, D. B. Jeffe, K. Trinlaus, et al., “Surgical Resection of the Primary Tumor Is Associated with Increased Long-Term Survival in Patients with Stage IV Breast Cancer after Controlling for Site of Metastasis,” Annals of Surgical Oncology, Vol. 14, No. 12, 2007, pp. 3345-3351. http://dx.doi.org/10.1245/s10434-007-9527-0
|
[19]
|
J. Ruiterkamp and F. M. Ernst, “The Role of Surgery in Metastatic Breast Cancer,” European Journal of Cancer, Vol. 47, No. Suppl 3, 2011, pp. S6-S22.
|
[20]
|
F. Petrelli and S. Barni, “Surgery of Primary Tumors in Stage IV Breast Cancer: An Updated Meta-Analysis of Published Studies with Meta-Regression,” Medical Oncology, Vol. 29, No. 5, 2012, pp. 3282-3290.
|
[21]
|
H. B. Neumann, M. Morrogh, M. Gonen, et al., “Stage IV Breast Cancer in the Era of Targeted Therapy: Does Surgery of the Primary Tumor Matter?” Cancer, Vol. 116, No. 5, 2010, pp. 1226-1233.
http://dx.doi.org/10.1002/cncr.24873
|
[22]
|
L. Cortesi, C. Cirilli, I. Rashid, E. Artioli and M. Federico, “Changes in Survival from Metastatic Breast Cancer during the Last Twenty-Years: A Population Based Study in Northern Italy,” ASCO Annual Meeting, 2009.
|
[23]
|
Federation of Breast Diseases Societies, “Local Surgery for Metastatic Breast Cancer,” Identifier: NCT00557986, Federation of Breast Diseases Societies, 2012.
www.clinicaltrials.gov
|